{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:07:02Z","timestamp":1791022022746,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.clim.2011.04.013","type":"journal-article","created":{"date-parts":[[2011,4,30]],"date-time":"2011-04-30T23:17:54Z","timestamp":1304205474000},"page":"36-48","source":"Crossref","is-referenced-by-count":30,"title":["Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms"],"prefix":"10.1016","volume":"141","author":[{"given":"Lili","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2011.04.013_bb0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0010","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2011.04.013_bb0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1196\/annals.1254.033","article-title":"Immunoregulation in experimental autoimmune myasthenia gravis \u2014 about T cells, antibodies, and endplates","volume":"998","author":"De Baets","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.clim.2011.04.013_bb0020","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","article-title":"C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells","volume":"178","author":"Wang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0025","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","article-title":"Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis","volume":"128","author":"Mu","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2011.04.013_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00296-004-0456-y","article-title":"Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis","volume":"25","author":"Drinda","year":"2005","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2011.04.013_bb0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2337\/diabetes.53.3.743","article-title":"Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA","volume":"53","author":"Valencia","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2011.04.013_bb0040","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.clim.2011.04.013_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nm831","article-title":"Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system","volume":"9","author":"Yan","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2011.04.013_bb0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.173.2.1399","article-title":"Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products","volume":"173","author":"Chen","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0055","doi-asserted-by":"crossref","first-page":"34834","DOI":"10.1074\/jbc.M302828200","article-title":"Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products","volume":"278","author":"Shanmugam","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2011.04.013_bb0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neurobiolaging.2008.05.017","article-title":"S100B\/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha","volume":"31","author":"Bianchi","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clim.2011.04.013_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2001.7732","article-title":"Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism","volume":"171","author":"Lue","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.clim.2011.04.013_bb0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/35012626","article-title":"Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases","volume":"405","author":"Taguchi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.clim.2011.04.013_bb0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","article-title":"The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses","volume":"108","author":"Schmidt","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2011.04.013_bb0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11883-002-0024-4","article-title":"Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes","volume":"4","author":"Wendt","year":"2002","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.clim.2011.04.013_bb0085","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.clim.2011.04.013_bb0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-4889(00)00087-2","article-title":"The biology of the receptor for advanced glycation end products and its ligands","volume":"1498","author":"Schmidt","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2011.04.013_bb0095","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.4049\/jimmunol.0901163","article-title":"Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus","volume":"183","author":"Iikuni","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/08916930500124122","article-title":"Immunosteroid as a regulator for Th1\/Th2 balance: its possible role in autoimmune diseases","volume":"38","author":"Matsuzaki","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2011.04.013_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bjo.2006.099192","article-title":"Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis","volume":"91","author":"Keino","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clim.2011.04.013_bb0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2249.2006.03283.x","article-title":"Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease","volume":"147","author":"Nielsen","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1615\/CritRevImmunol.v25.i2.10","article-title":"Th1 and Th2 lymphocytes in autoimmune disease","volume":"25","author":"Crane","year":"2005","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2006.07.004","article-title":"CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis","volume":"179","author":"Milani","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0125","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2011.04.013_bb0130","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-5728(01)00474-X","article-title":"Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis","volume":"122","author":"Goluszko","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.181.2.547","article-title":"Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction","volume":"181","author":"Gu","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2011.04.013_bb0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/clim.2000.4850","article-title":"Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis","volume":"95","author":"Wang","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2011.04.013_bb0155","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.4049\/jimmunol.161.6.2856","article-title":"The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis","volume":"161","author":"Balasa","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0160","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","article-title":"Th17: an effector CD4 T cell lineage with regulatory T cell ties","volume":"24","author":"Weaver","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2011.04.013_bb0165","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0170","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.4049\/jimmunol.181.6.4272","article-title":"RAGE ligation affects T cell activation and controls T cell differentiation","volume":"181","author":"Chen","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.04.013_bb0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.clim.2007.07.006","article-title":"CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production","volume":"125","author":"Bernard","year":"2007","journal-title":"Clin. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661611001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661611001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T14:51:29Z","timestamp":1686063089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661611001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1521661611001355"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2011.04.013","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}